SPD vs. XBI
Compare and contrast key facts about Simplify US Equity PLUS Downside Convexity ETF (SPD) and SPDR S&P Biotech ETF (XBI).
SPD and XBI are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. SPD is an actively managed fund by Simplify Asset Management Inc.. It was launched on Sep 3, 2020. XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SPD or XBI.
Key characteristics
| SPD | XBI | |
|---|---|---|
| YTD Return | 10.38% | 2.12% |
| 1Y Return | 23.53% | 7.63% |
| 3Y Return (Ann) | 3.57% | -10.51% |
| 5Y Return (Ann) | -2.39% | 2.06% |
| 10Y Return (Ann) | -2.39% | 8.46% |
| Sharpe Ratio | 2.36 | 0.23 |
| Daily Std Dev | 10.52% | 27.72% |
| Max Drawdown | -58.63% | -63.89% |
| Current Drawdown | -8.54% | -47.57% |
Correlation
The correlation between SPD and XBI is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SPD vs. XBI - Performance Comparison
In the year-to-date period, SPD achieves a 10.38% return, which is significantly higher than XBI's 2.12% return. Over the past 10 years, SPD has underperformed XBI with an annualized return of -2.39%, while XBI has yielded a comparatively higher 8.46% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
SPD vs. XBI - Expense Ratio Comparison
SPD has a 0.28% expense ratio, which is lower than XBI's 0.35% expense ratio.
Risk-Adjusted Performance
SPD vs. XBI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Simplify US Equity PLUS Downside Convexity ETF (SPD) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SPD vs. XBI - Dividend Comparison
SPD's dividend yield for the trailing twelve months is around 1.80%, more than XBI's 0.02% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SPD Simplify US Equity PLUS Downside Convexity ETF | 1.80% | 1.91% | 1.65% | 0.88% | 0.43% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XBI SPDR S&P Biotech ETF | 0.02% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% | 0.17% |
Drawdowns
SPD vs. XBI - Drawdown Comparison
The maximum SPD drawdown since its inception was -58.63%, smaller than the maximum XBI drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for SPD and XBI. For additional features, visit the drawdowns tool.
Volatility
SPD vs. XBI - Volatility Comparison
The current volatility for Simplify US Equity PLUS Downside Convexity ETF (SPD) is 3.03%, while SPDR S&P Biotech ETF (XBI) has a volatility of 6.72%. This indicates that SPD experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.